Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
National Cohort Study
45%
Working Diagnosis
37%
Testosterone Deficiency
33%
Cancer Risk
29%
Total Testosterone
29%
Itraconazole
28%
Clinically Significant
28%
Primary Aldosteronism
28%
Meta-analysis
28%
Hazard Ratio
28%
Comorbidity
26%
Insulin-like
25%
Growth Factors
25%
Survivors
22%
Disease Control
21%
Lymphoma Survivors
21%
Malignant Lymphoma
20%
Testosterone
18%
Age at Diagnosis
17%
Adenoma Size
17%
Hyperaldosteronism
17%
Acromegaly Diagnosis
16%
Hodgkin Lymphoma
16%
Male Survivors
16%
Population-based
16%
After Surgery
14%
Contralateral Suppression
14%
Prognostic Value
14%
Sex Differences
14%
Confidence Interval
14%
Clinical Features
14%
Erectile Dysfunction
14%
Interleukin-6
14%
YKL-40
14%
Biliary Tract Cancer
14%
Preoperative Blood Pressure
14%
Cancer Detection
14%
Diagnostic Biomarker
14%
Approaches to Studying
14%
Comorbidity Treatment
14%
Kidney Function
14%
Circulating Proteins
14%
C-reactive Protein
14%
Non-specific Symptoms
14%
Protein Signature
14%
Epidemiological Data
14%
Non-invasive Detection
14%
Epidemiological Indicators
14%
Neoplastic Disease
14%
Liver Cirrhosis
14%
Medicine and Dentistry
Acromegaly
100%
Cohort Analysis
44%
Primary Hyperaldosteronism
42%
Diseases
38%
Testosterone
32%
Comorbidity
29%
Contralateral
28%
Biological Marker
28%
Liquid Biopsy
28%
Androgen Deficiency
25%
Hazard Ratio
25%
Malignant Neoplasm
25%
Adrenalectomy
20%
Quality of Life
19%
Colorectal Carcinoma
19%
Sexual Dysfunction
17%
Aldosterone
17%
Hodgkin's Lymphoma
16%
Somatomedin C
15%
Early Diagnosis
15%
Cancer Diagnosis
15%
Blood Pressure
14%
Systematic Review
14%
Kidney Function
14%
BEACOPP
14%
Pheochromocytoma
14%
Paraganglioma
14%
Hemodynamic
14%
Provocation Test
14%
Captopril
14%
Musculoskeletal Disease
14%
Mass Spectrum
14%
Sex Differences
14%
Retrospective Cohort Study
14%
Cancer Prognosis
14%
Pancreas Cancer
14%
Prevalence
13%
Growth Hormone
12%
Erectile Dysfunction
12%
Area under the Curve
11%
Pancreas Adenocarcinoma
8%
Diagnostic Performance
8%
Cancer Treatment
8%
Phenoxybenzamine
7%
Infusion Fluid
7%
Osteoporosis
6%
Diagnosis
6%
Socioeconomic Status
6%
Systolic Blood Pressure
5%
Overall Survival
5%